{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T22:29:50Z","timestamp":1772749790901,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2000,9,1]],"date-time":"2000-09-01T00:00:00Z","timestamp":967766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2000,9,1]],"date-time":"2000-09-01T00:00:00Z","timestamp":967766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006310","name":"Medicinska Forskningsr\u00e5det","doi-asserted-by":"publisher","award":["14X-6834"],"award-info":[{"award-number":["14X-6834"]}],"id":[{"id":"10.13039\/501100006310","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006738","name":"Medicinska Fakulteten, Lunds Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2000,9]]},"DOI":"10.1016\/s0014-2999(00)00600-2","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T10:17:02Z","timestamp":1027592222000},"page":"239-245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":160,"title":["Improved glucose tolerance and insulin secretion by inhibition of dipeptidyl peptidase IV in mice"],"prefix":"10.1016","volume":"404","author":[{"given":"Bo","family":"Ahr\u00e9n","sequence":"first","affiliation":[]},{"given":"Jens J","family":"Holst","sequence":"additional","affiliation":[]},{"given":"Hans","family":"M\u00e5rtensson","sequence":"additional","affiliation":[]},{"given":"B\u00f6rk","family":"Balkan","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0014-2999(00)00600-2_BIB1","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/(SICI)1521-1878(199808)20:8<642::AID-BIES7>3.0.CO;2-K","article-title":"Glucagon-like peptide-1 (GLP-1): a gut hormone of potential interest in the treatment of diabetes","volume":"20","author":"Ahr\u00e9n","year":"1998","journal-title":"BioEssays"},{"key":"10.1016\/S0014-2999(00)00600-2_BIB2","series-title":"Advances in Molecular and Cell Biology","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1569-2558(08)60093-4","article-title":"Potentiators and inhibitors of insulin secretion","volume":"vol. 29","author":"Ahr\u00e9n","year":"1999"},{"key":"10.1016\/S0014-2999(00)00600-2_BIB3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0143-4179(88)90069-8","article-title":"Effects of peptide HI on basal and stimulated insulin and glucagon secretion in the mouse","volume":"11","author":"Ahr\u00e9n","year":"1988","journal-title":"Neuropeptides"},{"key":"10.1016\/S0014-2999(00)00600-2_BIB4","first-page":"E996","article-title":"Glucagon-like peptide-1 stimulates insulin secretion and glucose effectiveness in mice","volume":"277","author":"Ahr\u00e9n","year":"1999","journal-title":"Am. J. Physiol."},{"key":"10.1016\/S0014-2999(00)00600-2_BIB5","first-page":"473","article-title":"Effects of glucagon-like peptide-1 on islet function and insulin sensitivity in noninsulin-dependent diabetes mellitus","volume":"82","author":"Ahr\u00e9n","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/S0014-2999(00)00600-2_BIB6","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0026-0495(97)90175-X","article-title":"Dissociated insulinotropic sensitivity to glucose and carbachol in high-fat diet-induced insulin resistance in C57BL\/6J mice","volume":"46","author":"Ahr\u00e9n","year":"1997","journal-title":"Metabolism"},{"key":"10.1016\/S0014-2999(00)00600-2_BIB7","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1007\/s001250051445","article-title":"Inhibition of dipeptidyl peptidase IV with NVP-DPP728 increases plasma GLP-1 (7-36 amide) concentrations and improves oral glucose tolerance in obese Zucker rats","volume":"42","author":"Balkan","year":"1999","journal-title":"Diabetologia"},{"key":"10.1016\/S0014-2999(00)00600-2_BIB8","doi-asserted-by":"crossref","first-page":"764","DOI":"10.2337\/diabetes.47.5.764","article-title":"Dipeptidyl peptidase IV inhibition potentiates the insulinotropic effect of glucagon-like peptide-1 in the anesthetized pig","volume":"47","author":"Deacon","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/S0014-2999(00)00600-2_BIB9","first-page":"952","article-title":"Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo","volume":"80","author":"Deacon","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/S0014-2999(00)00600-2_BIB10","first-page":"E458","article-title":"Glucagon-like peptide 1 undergoes differential tissue-specific metabolism in the anesthetized pig","volume":"271","author":"Deacon","year":"1996","journal-title":"Am. J. Physiol."},{"key":"10.1016\/S0014-2999(00)00600-2_BIB11","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/00006676-199103000-00013","article-title":"GLP-1 and GLP-1(7-36) amide: Influences on basal and stimulated insulin and glucagon secretion in the mouse","volume":"6","author":"Fridolf","year":"1991","journal-title":"Pancreas"},{"key":"10.1016\/S0014-2999(00)00600-2_BIB12","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1056\/NEJM199205143262003","article-title":"Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus","volume":"326","author":"Gutniak","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/S0014-2999(00)00600-2_BIB13","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.2337\/diacare.20.12.1874","article-title":"GLP-1 tablet in type 2 diabetes in fasting and postprandial conditions","volume":"20","author":"Gutniak","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/S0014-2999(00)00600-2_BIB14","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1210\/endo.140.11.7143","article-title":"Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV activity in the capillaries supplying the L-cells of the porcine intestine","volume":"140","author":"Hansen","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/S0014-2999(00)00600-2_BIB15","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2337\/diabetes.47.11.1663","article-title":"Inhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetes","volume":"47","author":"Holst","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/S0014-2999(00)00600-2_BIB16","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0014-5793(87)81430-8","article-title":"Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut","volume":"211","author":"Holst","year":"1987","journal-title":"FEBS Lett."},{"key":"10.1016\/S0014-2999(00)00600-2_BIB17","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.2337\/diacare.19.11.1200","article-title":"The antidiabetogenic effect of GLP-1 is maintained during a 7-day treatment period and improves diabetic dyslipoproteinemia in NIDDM patients","volume":"19","author":"Juntti-Berggren","year":"1996","journal-title":"Diabetes Care"},{"key":"10.1016\/S0014-2999(00)00600-2_BIB18","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1210\/endo.136.8.7628397","article-title":"Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV","volume":"136","author":"Kieffer","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/S0014-2999(00)00600-2_BIB19","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0014-2999(96)00795-9","article-title":"Glucagon-like peptide-1 (9-36)amide is a major metabolite of glucagon-like peptide-1 (7-36)amide after in vivo administration to dogs, and it acts as an antagonist on the pancreatic receptor","volume":"318","author":"Knudsen","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/S0014-2999(00)00600-2_BIB20","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/S0140-6736(87)91194-9","article-title":"Glucagon-like peptide 1 7-36: a physiological incretin in man","volume":"2","author":"Kreymann","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/S0014-2999(00)00600-2_BIB21","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1046\/j.1365-201X.1997.00161.x","article-title":"Glucagon-like peptide-1 reduces hepatic glucose production indirectly through insulin and glucagon in humans","volume":"160","author":"Larsson","year":"1997","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/S0014-2999(00)00600-2_BIB22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0167-0115(99)00089-0","article-title":"Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides","volume":"85","author":"Mentlein","year":"1999","journal-title":"Regul. Pept."},{"key":"10.1016\/S0014-2999(00)00600-2_BIB23","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1432-1033.1993.tb17986.x","article-title":"Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1 (7-36)amide, and peptide histidine methionine and is responsible for their degradation in human serum","volume":"214","author":"Mentlein","year":"1993","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/S0014-2999(00)00600-2_BIB24","first-page":"E981","article-title":"Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans","volume":"273","author":"Nauck","year":"1997","journal-title":"Am. J. Physiol."},{"key":"10.1016\/S0014-2999(00)00600-2_BIB25","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s001250051165","article-title":"Is glucagon-like peptide 1 an incretin hormone?","volume":"42","author":"Nauck","year":"1999","journal-title":"Diabetologia"},{"key":"10.1016\/S0014-2999(00)00600-2_BIB26","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/BF00429088","article-title":"Glucagon-like peptide-1, a new hormone of the entero-insular axis","volume":"35","author":"\u00d8rskov","year":"1992","journal-title":"Diabetologia"},{"key":"10.1016\/S0014-2999(00)00600-2_BIB27","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.2337\/diab.47.8.1253","article-title":"Improved glucose tolerance in Zucker fatty rats by oral administration of the dipeptidyl peptidase IV inhibitor isoleucine thiazolidide","volume":"47","author":"Pederson","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/S0014-2999(00)00600-2_BIB28","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000201118","article-title":"Stimulation of truncated glucagon-like peptide-1 release from the isolated perfused canine ileum by glucose absorpion","volume":"55","author":"Sugiyama","year":"1994","journal-title":"Digestion"},{"key":"10.1016\/S0014-2999(00)00600-2_BIB29","first-page":"327","article-title":"Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36)amide in type 2 (non-insulin-dependent) diabetic patients","volume":"81","author":"Willms","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299900006002?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299900006002?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T03:57:07Z","timestamp":1762142227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299900006002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,9]]},"references-count":29,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2000,9]]}},"alternative-id":["S0014299900006002"],"URL":"https:\/\/doi.org\/10.1016\/s0014-2999(00)00600-2","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2000,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improved glucose tolerance and insulin secretion by inhibition of dipeptidyl peptidase IV in mice","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0014-2999(00)00600-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2000 Elsevier Science B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}